Rules and Regulations. Final rule; correction
255 words·~1 min read·
/register/2004/04/07/04-7815·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4910-13-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Parts 201, 606, and 610 [Docket No. 2002N-0204] Bar Code Label Requirement for Human Drug Products and Biological Products; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Final rule; correction. SUMMARY: The Food and Drug Administration
(FDA)is correcting a final rule that appeared in the **Federal Register** of February 26, 2004 (69 FR 9120). The document included typographical and inadvertent errors. This document corrects those errors. FOR FURTHER INFORMATION CONTACT: Philip L. Chao, Office of Policy and Planning (HF-23), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-0587. SUPPLEMENTARY INFORMATION: In FR Doc. 04-4249, appearing on page 9120 in the **Federal Register** of Thursday, February 26, 2004, the following corrections are made: 1. On page 9151, in the third column, the first sentence of the first full paragraph, is corrected to read “We estimate that the rule provides net benefits to society of $4.3 billion to $4.5 billion annually, depending on whether a discount rate of 3 percent or 7 percent is used.” 2. On page 9167, in the first column, the first sentence under the heading “ *P. Small Business Analysis and Discussion of Alternatives* ” is corrected to read “For the reasons cited in the following paragraphs, the agency certifies that the final rule will not have a significant economic impact on a substantial number of small entities.” Dated: March 31, 2004. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. 04-7815 Filed 4-6-04; 8:45 am]